David O. Watson, General Counsel at Apellis Pharmaceuticals, Inc. (APLS), sold 695 shares at $29.52 ($21K) on 2025-01-29, disclosed to the SEC on 2025-01-30.
Seasonal sale ($21k) by General Counsel — this insider has traded APLS in January in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| APLS | SELL | 2026-01-15 | $128K | — | Filing → |
| APLS | SELL | 2025-12-18 | $245K | — | Filing → |
| APLS | SELL | 2025-11-18 | $100K | — | Filing → |